Intrinsic Value of S&P & Nasdaq Contact Us

Baxter International Inc. BAX NYSE

NYSE • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
43/100
2/7 Pass
SharesGrow Intrinsic Value
$25.54
+45.2%
Analyst Price Target
$19.75
+12.3%

Financial Health Score — BAX

Baxter International Inc. (BAX) has an overall financial health rating of C+ with a composite score of 0 out of 5.

This suggests the company faces some financial challenges worth monitoring. Rating as of 2026-04-07.

C+
Overall Rating
2026-04-07

Rating History

Date Rating DCF ROE ROA D/E P/E P/B
2026-04-07 C+ -/5 -/5 -/5 -/5 -/5 -/5
2026-04-06 C+ -/5 -/5 -/5 -/5 -/5 -/5
2026-04-02 C+ -/5 -/5 -/5 -/5 -/5 -/5
2026-04-01 C+ -/5 -/5 -/5 -/5 -/5 -/5
2026-03-31 C+ -/5 -/5 -/5 -/5 -/5 -/5
2026-03-30 C+ -/5 -/5 -/5 -/5 -/5 -/5
2026-03-27 C+ -/5 -/5 -/5 -/5 -/5 -/5
2026-03-26 C+ -/5 -/5 -/5 -/5 -/5 -/5
2026-03-25 C+ -/5 -/5 -/5 -/5 -/5 -/5
2026-03-24 C+ -/5 -/5 -/5 -/5 -/5 -/5
2026-03-23 C+ -/5 -/5 -/5 -/5 -/5 -/5
2026-03-20 C+ -/5 -/5 -/5 -/5 -/5 -/5
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message